Literature DB >> 29371291

Multiomics Integration Reveals the Landscape of Prometastasis Metabolism in Hepatocellular Carcinoma.

Yongmei Li1, Hao Zhuang1,2, Xinran Zhang1, Yuan Li1, Yun Liu1, Xianfu Yi3, Guoxuan Qin4, Wen Wei5, Ruibing Chen6.   

Abstract

The systematic investigation of gene mutation and expression is important to discover novel biomarkers and therapeutic targets in cancers. Here, we integrated genomics, transcriptomics, proteomics, and metabolomics to analyze three hepatocellular carcinoma (HCC) cell lines with differential metastatic potentials. The results revealed the profile of the prometastasis metabolism potentially associated with HCC metastasis. The multiomic analysis identified 12 genes with variations at multiple levels from three metabolic pathways, including glycolysis, starch, and sucrose metabolism, and glutathione metabolism. Furthermore, uridine diphosphate (UDP)-glucose pyrophosphorylase 2 (UGP2), was observed to be persistently up-regulated with increased metastatic potential. UGP2 overexpression promoted cell migration and invasion and enhanced glycogenesis in vitro The role of UGP2 in metastasis was further confirmed using a tumor xenograft mouse model. Taken together, the compendium of multiomic data provides valuable insights in understanding the roles of shifted cellular metabolism in HCC metastasis.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29371291      PMCID: PMC5880115          DOI: 10.1074/mcp.RA118.000586

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  44 in total

1.  A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data.

Authors:  Heng Li
Journal:  Bioinformatics       Date:  2011-09-08       Impact factor: 6.937

2.  Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma.

Authors:  Shi L Sheng; Jian J Liu; Yun H Dai; Xiao G Sun; Xiao P Xiong; Gang Huang
Journal:  FEBS J       Date:  2012-09-13       Impact factor: 5.542

3.  Evidence for an alternative glycolytic pathway in rapidly proliferating cells.

Authors:  Matthew G Vander Heiden; Jason W Locasale; Kenneth D Swanson; Hadar Sharfi; Greg J Heffron; Daniel Amador-Noguez; Heather R Christofk; Gerhard Wagner; Joshua D Rabinowitz; John M Asara; Lewis C Cantley
Journal:  Science       Date:  2010-09-17       Impact factor: 47.728

4.  Autocrine motility factor modulates EGF-mediated invasion signaling.

Authors:  Dhong Hyo Kho; Tianpeng Zhang; Vitaly Balan; Yi Wang; Seung-Wook Ha; Youming Xie; Avraham Raz
Journal:  Cancer Res       Date:  2014-02-27       Impact factor: 12.701

Review 5.  Metabolic changes associated with tumor metastasis, part 2: Mitochondria, lipid and amino acid metabolism.

Authors:  Paolo E Porporato; Valéry L Payen; Bjorn Baselet; Pierre Sonveaux
Journal:  Cell Mol Life Sci       Date:  2015-12-08       Impact factor: 9.261

6.  Metastasis and Oxidative Stress: Are Antioxidants a Metabolic Driver of Progression?

Authors:  Maria Peiris-Pagès; Ubaldo E Martinez-Outschoorn; Federica Sotgia; Michael P Lisanti
Journal:  Cell Metab       Date:  2015-12-01       Impact factor: 27.287

7.  Pyruvate kinase M2 in blood circulation facilitates tumor growth by promoting angiogenesis.

Authors:  Liangwei Li; Yinwei Zhang; Jingjuan Qiao; Jenny J Yang; Zhi-Ren Liu
Journal:  J Biol Chem       Date:  2014-07-28       Impact factor: 5.157

8.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

Review 9.  Recent advances in liver resection for hepatocellular carcinoma.

Authors:  Zenichi Morise; Norihiko Kawabe; Hirokazu Tomishige; Hidetoshi Nagata; Jin Kawase; Satoshi Arakawa; Rie Yoshida; Masashi Isetani
Journal:  Front Surg       Date:  2014-06-16

10.  The metabolic co-regulator PGC1α suppresses prostate cancer metastasis.

Authors:  Veronica Torrano; Lorea Valcarcel-Jimenez; Jason W Locasale; Roger R Gomis; Ana Rosa Cortazar; Xiaojing Liu; Jelena Urosevic; Mireia Castillo-Martin; Sonia Fernández-Ruiz; Giampaolo Morciano; Alfredo Caro-Maldonado; Marc Guiu; Patricia Zúñiga-García; Mariona Graupera; Anna Bellmunt; Pahini Pandya; Mar Lorente; Natalia Martín-Martín; James David Sutherland; Pilar Sanchez-Mosquera; Laura Bozal-Basterra; Amaia Zabala-Letona; Amaia Arruabarrena-Aristorena; Antonio Berenguer; Nieves Embade; Aitziber Ugalde-Olano; Isabel Lacasa-Viscasillas; Ana Loizaga-Iriarte; Miguel Unda-Urzaiz; Nikolaus Schultz; Ana Maria Aransay; Victoria Sanz-Moreno; Rosa Barrio; Guillermo Velasco; Paolo Pinton; Carlos Cordon-Cardo; Arkaitz Carracedo
Journal:  Nat Cell Biol       Date:  2016-05-23       Impact factor: 28.824

View more
  9 in total

1.  Identification of Context-Specific Fitness Genes Associated With Metabolic Rearrangements for Prognosis and Potential Treatment Targets for Liver Cancer.

Authors:  Shizhe Yu; Haoren Wang; Jie Gao; Long Liu; Xiaoyan Sun; Zhihui Wang; Peihao Wen; Xiaoyi Shi; Jihua Shi; Wenzhi Guo; Shuijun Zhang
Journal:  Front Genet       Date:  2022-05-13       Impact factor: 4.772

2.  Integration of metabolomics and expression of enolase-phosphatase 1 links to hepatocellular carcinoma progression.

Authors:  Hao Zhuang; Zhaoyan Qiang; Xiaowen Shao; Huan Wang; Yamei Dang; Zun Wang; Fei Wu; Wen Wei; Yongmei Li
Journal:  Theranostics       Date:  2019-05-26       Impact factor: 11.556

3.  Discovery of Novel Inhibitors Targeting Multi-UDP-hexose Pyrophosphorylases as Anticancer Agents.

Authors:  Yueqin Yang; Hariprasad Vankayalapati; Manshu Tang; Yingbo Zheng; Yingri Li; Cong Ma; Kent Lai
Journal:  Molecules       Date:  2020-02-03       Impact factor: 4.411

4.  Identification of a Subtype of Hepatocellular Carcinoma with Poor Prognosis Based on Expression of Genes within the Glucose Metabolic Pathway.

Authors:  Xiaoli Zhang; Jin Li; Kalpana Ghoshal; Soledad Fernandez; Lang Li
Journal:  Cancers (Basel)       Date:  2019-12-14       Impact factor: 6.639

5.  Plasma metabolomic profile associated with fatigue in cancer patients.

Authors:  Li Rebekah Feng; Jennifer J Barb; Jeniece Regan; Leorey N Saligan
Journal:  Cancer Med       Date:  2021-02-03       Impact factor: 4.452

6.  Increased levels of acidic free-N-glycans, including multi-antennary and fucosylated structures, in the urine of cancer patients.

Authors:  Ken Hanzawa; Miki Tanaka-Okamoto; Hiroko Murakami; Noriko Suzuki; Mikio Mukai; Hidenori Takahashi; Takeshi Omori; Kenji Ikezawa; Kazuyoshi Ohkawa; Masayuki Ohue; Shunji Natsuka; Yasuhide Miyamoto
Journal:  PLoS One       Date:  2022-04-12       Impact factor: 3.240

7.  Multi-Omics Analysis Revealed a Significant Alteration of Critical Metabolic Pathways Due to Sorafenib-Resistance in Hep3B Cell Lines.

Authors:  Kholoud Y I Abushawish; Sameh S M Soliman; Alexander D Giddey; Hamza M Al-Hroub; Muath Mousa; Karem H Alzoubi; Waseem El-Huneidi; Eman Abu-Gharbieh; Hany A Omar; Sara M Elgendy; Yasser Bustanji; Nelson C Soares; Mohammad H Semreen
Journal:  Int J Mol Sci       Date:  2022-10-09       Impact factor: 6.208

8.  UDP-glucose pyrophosphorylase 2, a regulator of glycogen synthesis and glycosylation, is critical for pancreatic cancer growth.

Authors:  Andrew L Wolfe; Qingwen Zhou; Eneda Toska; Jacqueline Galeas; Angel A Ku; Richard P Koche; Sourav Bandyopadhyay; Maurizio Scaltriti; Carlito B Lebrilla; Frank McCormick; Sung Eun Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-03       Impact factor: 12.779

9.  Loss of UGP2 in brain leads to a severe epileptic encephalopathy, emphasizing that bi-allelic isoform-specific start-loss mutations of essential genes can cause genetic diseases.

Authors:  Elena Perenthaler; Anita Nikoncuk; Soheil Yousefi; Woutje M Berdowski; Maysoon Alsagob; Ivan Capo; Herma C van der Linde; Paul van den Berg; Edwin H Jacobs; Darija Putar; Mehrnaz Ghazvini; Eleonora Aronica; Wilfred F J van IJcken; Walter G de Valk; Evita Medici-van den Herik; Marjon van Slegtenhorst; Lauren Brick; Mariya Kozenko; Jennefer N Kohler; Jonathan A Bernstein; Kristin G Monaghan; Amber Begtrup; Rebecca Torene; Amna Al Futaisi; Fathiya Al Murshedi; Renjith Mani; Faisal Al Azri; Erik-Jan Kamsteeg; Majid Mojarrad; Atieh Eslahi; Zaynab Khazaei; Fateme Massinaei Darmiyan; Mohammad Doosti; Ehsan Ghayoor Karimiani; Jana Vandrovcova; Faisal Zafar; Nuzhat Rana; Krishna K Kandaswamy; Jozef Hertecant; Peter Bauer; Mohammed A AlMuhaizea; Mustafa A Salih; Mazhor Aldosary; Rawan Almass; Laila Al-Quait; Wafa Qubbaj; Serdar Coskun; Khaled O Alahmadi; Muddathir H A Hamad; Salem Alwadaee; Khalid Awartani; Anas M Dababo; Futwan Almohanna; Dilek Colak; Mohammadreza Dehghani; Mohammad Yahya Vahidi Mehrjardi; Murat Gunel; A Gulhan Ercan-Sencicek; Gouri Rao Passi; Huma Arshad Cheema; Stephanie Efthymiou; Henry Houlden; Aida M Bertoli-Avella; Alice S Brooks; Kyle Retterer; Reza Maroofian; Namik Kaya; Tjakko J van Ham; Tahsin Stefan Barakat
Journal:  Acta Neuropathol       Date:  2019-12-09       Impact factor: 17.088

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.